how to transition from semaglutide to tirzepatide Weight Loss Medications Like and Work and Why Medical Supervision is Essential Switching from Semaglutide to Tirzepatide:

Promote immunity & detoxify from within

doi: 10.3389/fendo.2021.741764

The MariTide Phase 2 data presented in November 2024 were highly significant: MariTide demonstrated robust weight loss at 52 weeks with no plateau meaning continued weight loss trajectory at the end of the study period, unlike semaglutide and tirzepatide which show plateau effects and significant improvements in cardiometabolic parameters

And while anecdotal evidence may suggest benefits, the scientific data is less clear

Selection bias plays a role, as satisfied customers are more likely to leave reviews

This change follows prior updates communicated in December 2024 and August 2025 regarding the auto-approval policy